M J Frank, A M Abdulla, M I Canedo, R E Saylors. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAdolescentAdultAnti-Arrhythmia Agents/therapeutic useArrhythmias, Cardiac/drug therapyArrhythmias, Cardiac/etiologyArrhythmias, Cardiac/therapyCardiomyopathy, Hypertrophic/complicationsCardiomyopathy, Hypertrophic/drug therapyCardiomyopathy, Hypertrophic/therapyDizziness/drug therapyDizziness/etiologyDose-Response Relationship, DrugElectrocardiographyFemaleFollow-Up StudiesHemodynamicsHumansMaleMiddle AgedPacemaker, ArtificialPropranolol/administration & dosagePropranolol/adverse effectsPropranolol/therapeutic useRetrospective StudiesSyncope/drug therapySyncope/etiology
Substances: See more » Anti-Arrhythmia AgentsPropranolol
Year: 1978 PMID: 569434 DOI: 10.1016/0002-9149(78)90687-2
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778